-+ 0.00%
-+ 0.00%
-+ 0.00%

Lakewood-Amedex Biotherapeutics Redeems Series C Preferred Stock for $1,270,970

PUBT·11/10/2026 22:21:56
Listen to the news
Lakewood-Amedex Biotherapeutics Redeems Series C Preferred Stock for $1,270,970
  • Lakewood-Amedex Biotherapeutics today completed redemption of 127,097 shares of Series C Convertible Preferred Stock for $1.27 million.
  • The redemption used cash on hand under a November 2, 2026, agreement with Shakawe Capital.
  • No preferred stock remains outstanding, eliminating potential conversion dilution and associated financing restrictions. No indebtedness for borrowed money remains outstanding.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lakewood-Amedex Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-118127), on November 10, 2026, and is solely responsible for the information contained therein.